Catalina Capital Group LLC Has $919,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Catalina Capital Group LLC lessened its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 56.5% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 1,755 shares of the healthcare conglomerate's stock after selling 2,279 shares during the period. Catalina Capital Group LLC's holdings in UnitedHealth Group were worth $919,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. Norges Bank acquired a new position in shares of UnitedHealth Group in the 4th quarter valued at approximately $6,375,744,000. GAMMA Investing LLC raised its holdings in UnitedHealth Group by 56,142.1% in the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares in the last quarter. Raymond James Financial Inc. acquired a new position in UnitedHealth Group during the 4th quarter worth $1,914,740,000. Amundi raised its stake in shares of UnitedHealth Group by 97.2% in the 4th quarter. Amundi now owns 6,069,100 shares of the healthcare conglomerate's stock valued at $3,183,132,000 after purchasing an additional 2,991,470 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in UnitedHealth Group by 36.6% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares in the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the company. Deutsche Bank Aktiengesellschaft reduced their price objective on UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Bank of America cut shares of UnitedHealth Group from a "buy" rating to a "neutral" rating and cut their target price for the stock from $560.00 to $350.00 in a report on Wednesday, May 14th. KeyCorp dropped their price target on UnitedHealth Group from $450.00 to $400.00 and set an "overweight" rating on the stock in a research report on Monday, June 2nd. TD Securities restated a "hold" rating and set a $308.00 price objective (down from $520.00) on shares of UnitedHealth Group in a research note on Monday, May 19th. Finally, Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Saturday, May 24th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and sixteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $426.52.

Insider Activity at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the business's stock in a transaction on Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, with a total value of $491,786.40. Following the completion of the purchase, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The shares were bought at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the completion of the acquisition, the chief executive officer now owns 679,493 shares of the company's stock, valued at $196,081,295.01. This trade represents a 14.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. Over the last quarter, insiders purchased 109,408 shares of company stock worth $31,607,768. 0.28% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH traded down $1.97 during trading on Thursday, reaching $306.90. The stock had a trading volume of 11,176,139 shares, compared to its average volume of 7,300,839. The stock has a market capitalization of $278.40 billion, a PE ratio of 12.85, a P/E/G ratio of 1.45 and a beta of 0.44. UnitedHealth Group Incorporated has a 52 week low of $248.88 and a 52 week high of $630.73. The business's 50-day moving average price is $370.86 and its 200 day moving average price is $467.96. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. During the same quarter in the previous year, the business posted $6.91 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th will be given a $2.21 dividend. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.88%. The ex-dividend date of this dividend is Monday, June 16th. UnitedHealth Group's dividend payout ratio (DPR) is currently 37.02%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.